Investing.com -- Kairos Pharma Ltd (NYSE: KAPA) stock surged 165% after the clinical-stage biopharmaceutical company reported positive safety results from its ongoing Phase 2 clinical trial of ENV-105 ...

“The purpose of the campaign was for men to engage with each other to share ideas and issues of gender violence. It was said by one of the speakers that gender-based violence does not choose whether ...